Detailed Information on Publication Record
2017
Selective IgM Deficiency: Clinical and Laboratory Features of 17 Patients and a Review of the Literature
CHOVANCOVÁ, Zita, Pavlina KRALICKOVA, Alena PEJCHALOVÁ, Marketa BLOOMFIELD, Jana NECHVÁTALOVÁ et. al.Basic information
Original name
Selective IgM Deficiency: Clinical and Laboratory Features of 17 Patients and a Review of the Literature
Authors
CHOVANCOVÁ, Zita (203 Czech Republic, guarantor, belonging to the institution), Pavlina KRALICKOVA (203 Czech Republic), Alena PEJCHALOVÁ (203 Czech Republic), Marketa BLOOMFIELD (203 Czech Republic), Jana NECHVÁTALOVÁ (203 Czech Republic, belonging to the institution), Marcela VLKOVÁ (203 Czech Republic, belonging to the institution) and Jiří LITZMAN (203 Czech Republic, belonging to the institution)
Edition
Journal of Clinical Immunology, New York, Springer, 2017, 0271-9142
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30102 Immunology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 4.227
RIV identification code
RIV/00216224:14110/17:00098289
Organization unit
Faculty of Medicine
UT WoS
000407597600011
Keywords in English
Selective IgM deficiency; primary immunodeficiency; infections; autoimmunity; allergy
Tags
Tags
International impact, Reviewed
Změněno: 7/3/2018 16:08, Soňa Böhmová
Abstract
V originále
Primary selective IgM deficiency (sIgMD) is a primary immunodeficiency with unclear pathogenesis and a low number of published cases. We reviewed clinical and laboratory manifestations of 17 sIgMD patients. Serum IgM, IgG, and its subclasses, IgA, IgE, antibodies against tetanus toxoid, pneumococcal polysaccharides and Haemophilus influenzae type b, isohemagglutinins, and T and B lymphocyte subsets, expressions of IgM on B cells and B lymphocyte production of IgM were compared with previously reported case reports and a small series of patients, which included 81 subjects in total. We found that some patients in our cohort (OC) and published cases (PC) had increased IgE levels (OC 7/15; PC 21/37), decreased IgG4 levels (OC 5/14), very low titers of isohemagglutinins (OC 8/8; PC 18/21), increased transitional B cell counts (OC 8/9), decreased marginal zone B cell counts (OC 8/9), and increased 21(low) B cell counts (OC 7/9). Compared with the PC (20/20), only two of five OC patients showed very low or undetectable production of IgM after stimulation. A majority of the patients had normal antibody production to protein and polysaccharide antigens, basic lymphocyte subset counts, and expression of surface IgM molecules on B cells. Low IgM levels are associated with various immunopathological disorders; however, pathogenic mechanisms leading to decreased IgM serum level in selective IgM deficiency remain unclear. Moreover, it is difficult to elucidate how strong these associations are and if these immunopathological conditions are primary or secondary.